Otsuka Sues Zydus To Block Generic Abilify
Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary Zydus Pharmaceuticals USA Inc. have become the latest targets of Otsuka Pharmaceutical Co. Ltd.'s legal campaign to prevent the launch of a...To view the full article, register now.
Already a subscriber? Click here to view full article